Researchers have used CRISPR-Cas9 to target DNA sequences
specific to cancer, shrinking tumors and improving the survival rates of
cancer-stricken mice
(Credit: vchalup2/Depositphotos)
The CRISPR-Cas9 genome editing system can do some pretty amazing things, giving us new ways to fight muscular dystrophy, blindness, and even HIV.
But at the top of its hit list is cancer, and now researchers from the
University of Pittsburgh have used the tool to target what they call
cancer's command center, in a treatment that's been shown in mice to
shrink aggressive tumors and increase survival rates without harming
healthy cells. Read more. . .
